- Trials with a EudraCT protocol (2,925)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,925 result(s) found.
Displaying page 1 of 147.
EudraCT Number: 2017-004506-18 | Sponsor Protocol Number: LYMRIT-37-07 | Start Date*: 2018-06-13 | |||||||||||
Sponsor Name:Nordic Nanovector ASA | |||||||||||||
Full Title: A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1) | |||||||||||||
Medical condition: Follicular lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004148-53 | Sponsor Protocol Number: M18ICR | Start Date*: 2019-03-19 | |||||||||||
Sponsor Name:NKI-AVL | |||||||||||||
Full Title: ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736) | |||||||||||||
Medical condition: Metastatic urothelial carcinoma patients or patients with irresectable disease who were previously treated with chemotherapy - or are cisplatin-ineligible - and have progressed during or after trea... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003958-16 | Sponsor Protocol Number: NL63056.018.17 | Start Date*: 2018-08-10 | |||||||||||
Sponsor Name:Academic Medical Center, University of Amsterdam | |||||||||||||
Full Title: Effect of Reslizumab on small airways in asthma. RESSAPEA | |||||||||||||
Medical condition: 1. Patients with severe eosinophilic asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003088-79 | Sponsor Protocol Number: ABR66722 | Start Date*: 2018-11-27 |
Sponsor Name:Radboudumc | ||
Full Title: First line Lutetium-177-PSMA-617 radioligand therapy in metastatic castrate resistant prostate cancer. | ||
Medical condition: Patients with mCRPC, PSMA expressing, clinical and/or radiological progressive castrate resistant metastatic prostate cancer without any previous disease related systemic therapy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004978-34 | Sponsor Protocol Number: RBHP2017BACHOUMAS | Start Date*: 2018-12-04 |
Sponsor Name:CHU de Clermont-ferrand | ||
Full Title: Efficacy of Testosterone gel to restore normal serum values of testosterone during the acute phase of critical illness in adult ICU patients. An open-label parallel randomized controlled pilot study | ||
Medical condition: - Hypermetabolism in ICU, loss of muscle mass and functional disability after ICU - ICU acquired hypogonadism - Treatment with testosterone gel in ICU | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004529-17 | Sponsor Protocol Number: YO39609 | Start Date*: 2018-07-17 | ||||||||||||||||
Sponsor Name:F. Hoffman-La Roche Ltd | ||||||||||||||||||
Full Title: A PHASE Ib/II, OPEN-LABEL, MULTICENTER, RANDOMIZED, UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH LOCALLY ADVANCED UNRESE... | ||||||||||||||||||
Medical condition: Locally advanced unresectable or Metastatic gastric or gastroesophageal junction cancer or esophageal cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003253-41 | Sponsor Protocol Number: PMC008 | Start Date*: 2018-09-11 | |||||||||||
Sponsor Name:Polish Myeloma Consortium | |||||||||||||
Full Title: PRE-emptive DAratumumab Therapy Of minimal Residual disease reappearance or biochemical relapse in multiple myeloma (PREDATOR). | |||||||||||||
Medical condition: Multiple Myeloma and Minimal Residual Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000875-34 | Sponsor Protocol Number: MM1807 | Start Date*: 2018-05-30 | |||||||||||
Sponsor Name:National Center for Cancer Immune Therapy | |||||||||||||
Full Title: Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids | |||||||||||||
Medical condition: Metastatic melanoma with brain metastasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001440-18 | Sponsor Protocol Number: IACI2016 | Start Date*: 2018-05-30 |
Sponsor Name:university medical center utrecht | ||
Full Title: Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls | ||
Medical condition: cystic fibrosis and healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004564-35 | Sponsor Protocol Number: 205739 | Start Date*: 2018-08-14 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd. | |||||||||||||
Full Title: A Phase IIa Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study to Investigate the Clinical Efficacy, Safety, and Tolerability of Nemiralisib (GSK2269557) in Symptomatic COPD Particip... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD)/chronic bronchitis and emphysema | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) NL (Prematurely Ended) ES (Prematurely Ended) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003008-30 | Sponsor Protocol Number: 16/0730 | Start Date*: 2020-07-01 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled single-site study of high dose simvastatin treatment for secondary progressive multiple sclerosis: impact on vascular perfusion and oxidative damage | |||||||||||||
Medical condition: Multiple Sclerosis (Secondary Progressive) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003943-20 | Sponsor Protocol Number: DX-2930-03 | Start Date*: 2016-03-31 | |||||||||||
Sponsor Name:Dyax Corp., an indirect, wholly-owned subsidiary of Shire plc. | |||||||||||||
Full Title: HELP Study™: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX 2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE) | |||||||||||||
Medical condition: Hereditary angioedema (HAE) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004903-33 | Sponsor Protocol Number: IBM4809 | Start Date*: 2018-06-18 | |||||||||||
Sponsor Name:Orphazyme A/S | |||||||||||||
Full Title: Phase 2/3 Study of Arimoclomol in Inclusion Body Myositis (IBM) A Randomized, Double-blind, Placebo-Controlled Trial | |||||||||||||
Medical condition: Sporadic Inclusion Body Myositis (sIBM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000010-38 | Sponsor Protocol Number: PAEDMED_v1.0 | Start Date*: 2018-03-20 |
Sponsor Name:Department of Clinical Pharmacology/Medical University of Vienna | ||
Full Title: Development of intravascular microdialysis as a tool for therapeutic drug monitoring in children. | ||
Medical condition: cohort A: We will administer a single dose of vancomycin, cefuroxime or gentamicin to healthy volunteers. The administration of the antibiotics in cohort A is for study purposes only. cohort B: We... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000299-13 | Sponsor Protocol Number: NVD003-CLN01 | Start Date*: 2018-05-17 |
Sponsor Name:Novadip Biosciences | ||
Full Title: A prospective multicentre single-arm study in adults to evaluate the safety and preliminary efficacy of the autologous 3D osteogenic implant NVD-003 for bone reconstruction for the treatment of rec... | ||
Medical condition: Patients with documented recalcitrant lower limb nonunion, meaning a single, meta- and/or diaphyseal nonunion defect of femur or tibia after at least one failed reconstructive surgical attempt. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) LU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003112-53 | Sponsor Protocol Number: TIP | Start Date*: 2018-10-01 | ||||||||||||||||
Sponsor Name:Vejle Hospital | ||||||||||||||||||
Full Title: Predictive value of in-vitro testing anti-cancer therapy sensitivity on tumoroids from patients with metastatic pancreatic cancer | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000307-17 | Sponsor Protocol Number: 69HCL16_0743 | Start Date*: 2018-07-19 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Microcirculatory and Macrocirculatory Effects of Landiolol on Postoperative Atrial Fibrillation: a Randomized Study. MMELPOAF study. | |||||||||||||
Medical condition: Postoperative Atrial Fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000016-19 | Sponsor Protocol Number: PSCs | Start Date*: 2018-04-04 |
Sponsor Name:Universitair ziekenhuis Brussel | ||
Full Title: Randomized comparative double blind prospective study with hyperbaric prilocaine 2 % and 3 different doses of sufentanil for elective caesarean section. | ||
Medical condition: Healthy pregnant women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000482-36 | Sponsor Protocol Number: CL02-ORY-1001AML | Start Date*: 2018-09-07 | |||||||||||
Sponsor Name:Oryzon Genomics S. A. | |||||||||||||
Full Title: A pilot study to assess the safety, tolerability, dose finding and efficacy of ORY-1001 in combination with azacitidine in older patients with AML in first line therapy. | |||||||||||||
Medical condition: Patients with acute mieloyd leukemia (AML) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003793-13 | Sponsor Protocol Number: 2017_07 | Start Date*: 2018-03-22 | |||||||||||
Sponsor Name:centre hospitalier et universitaire de Lille | |||||||||||||
Full Title: Arrêt précoce du traitement antifongique empirique en réanimation guidé par dosages sériques de biomarqueurs fongiques : Etude randomisée contrôlée | |||||||||||||
Medical condition: INFECTION INVASIVE A CANDIDA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
